RT Book, Section A1 Tinoco, Roberto A1 Crowe, James E. A2 Brunton, Laurence L. A2 Hilal-Dandan, Randa A2 Knollmann, Björn C. SR Print(0) ID 1162539971 T1 Immune Globulins and Vaccines T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259584732 LK accessanesthesiology.mhmedical.com/content.aspx?aid=1162539971 RD 2024/10/14 AB AbbreviationsACIP: Advisory Committee on Immunization PracticesADCC: antibody-dependent cell-mediated cytotoxicityAID: activation-induced cytidine deaminaseaP: acellular pertussisAPC: antigen-presenting cellASD: autism spectrum disorderAVA: anthrax vaccine adsorbedBCG: bacille Calmette-GuérinBCR: B cell receptorCDC: Centers for Disease Control and PreventionCoP: correlate of protectionCRM: cross-reactive materialDTaP: diphtheria and tetanus toxoids and acellular pertussisDTP: diphtheria and tetanus toxoids and pertussisEMA: European Medicines AgencyFab: fragment, antigen-bindingFc: fragment crystallizableGBS: Guillian-Barré syndromeH1N1: hemagglutinin type 1 and neuraminidase type 1H2N2: hemagglutinin type 2 and neuraminidase type 2H3N2: hemagglutinin type 3 and neuraminidase type 2HA: hemagglutininHbOC: Haemophilus influenzae type b oligosaccharide conjugateHib: Haemophilus influenzae type bHIV: human immunodeficiency virusHPV: human papillomavirusIgG: immunoglobulin, class GIIV: inactivated influenza vaccineIOM: Institute of MedicineIPV: inactivated poliovirus (vaccine)JE: Japanese encephalitisJE-MB: Japanese encephalitis mouse brainJE-VC: Japanese encephalitis Vero cellmCoP: mechanistic correlates of protectionMCV4: meningococcal vaccine 4MeV: measles virusMMR: measles-mumps-rubellaMMRV: measles-mumps-rubella-varicellaMVA: modified vaccinia AnkaraNA: neuraminidasenCoP: nonmechanistic correlates of protectionPCV13: pneumococcal conjugate vaccine 13 valentPRP: polyribosylribitol phosphatePRP-OMPC: polyribosylribitol phosphate outer membrane protein conjugatePRP-T: polyribosylribitol phosphate tetanusRAG: recombination-activating geneRSV: respiratory syncytial virusSAE: serious adverse eventSAGE: Strategic Advisory Group of ExpertsSIDS: sudden infant death syndromeTB: Mycobacterium tuberculosisTd: tetanus toxoid and reduced diphtheria toxoidTdap: tetanus toxoid, reduced diphtheria toxoid, acellular pertussisVDJ: variable, diversity, joiningVLP: virus-like particleVZV: varicella zoster virusWHO: World Health Organization